<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="mena-mig01/PMC5629135/results/search/country/results.xml">
  <result pre="of British Columbia, [2], 0000 0004 0634 1084grid.412603.2College of Pharmacy," exact="Qatar" post="University, [3], grid.413941.aDepartment of Pharmacy, Children’s and Women’s Health"/>
  <result pre="Genotype(s)/reported allelic frequencies percentage Pharmacokinetic outcomes Aynacioglu et al. [42]" exact="Turkey" post="Outpatients (n = 280); healthy volunteers (n = 218)"/>
  <result pre="0.43 (0.39–0.47)0.26 (0.21–0.31)0.21 (0.18–0.24)0.14 (0.13–0.14)Not observed0.02a Kerb et al. [43]" exact="Turkey" post="Healthy volunteers (n = 96) 300 mg PO ×"/>
  <result pre="(r2 = 0.154, p = 0.0002) Ozkaynakci et al. [44]" exact="Turkey" post="Epilepsy clinic outpatients taking PHT mono- or polytherapy (n"/>
  <result pre="***p &amp;lt; 0.005, †p &amp;lt; 0.001 Alhazzani et al. [45]" exact="Saudi Arabia" post="Epileptic patients taking PHT monotherapy: drug responsive (n ="/>
  <result pre="32 (0.16)6 (0.08)631 (0.48)33.3 (0.4)0.42 (0.21) Ebid et al. [46]" exact="Egypt" post="Epilepsy clinic outpatients taking PHT for partial (n ="/>
  <result pre="*1/*1 *1/*2 *1/*3 *2/*2 *2/*3 *3/*3 *1 *2 *3 [47]" exact="Egypt" post="Healthy volunteers 247 66.4 19.0 11.7 2.4 0 0.4"/>
  <result pre="66.4 19.0 11.7 2.4 0 0.4 81.8 11.9 6.3 [48]" exact="Egypt" post="Healthy volunteers (n = 154), patients taking maintenance warfarin"/>
  <result pre="81.5 4.5 8.5 4.5 0.5 0.5 88.0 7.0 5.0 [49]" exact="Egypt" post="Warfarin-resistant patients 41 60.9 19.5 19.5 0 0 0"/>
  <result pre="73.3 20.0 6.7 0 0 0 86.7 10.0 3.3 [50]" exact="Egypt" post="Patients taking maintenance warfarin 63 76.2 7.9 6.3 3.2"/>
  <result pre="76.2 7.9 6.3 3.2 0 6.3 83.4 7.1 9.5 [51]" exact="Egypt" post="Patients taking maintenance warfarin 84 83.3 NA 11.9 NA"/>
  <result pre="39.0 41.0 9.0 2.0 9.0 0 64.0 27.0 9.0 [57]" exact="Jordan" post="Healthy volunteers 263 62.7 21.7 12.2 1.9 1.5 0"/>
  <result pre="62.7 21.7 12.2 1.9 1.5 0 79.7 13.5 6.8 [58]" exact="Kuwait" post="Patients taking maintenance warfarin 108 69.4 21.3 6.5 0"/>
  <result pre="69.4 21.3 6.5 0 2.8 0 83.4 12.0 4.6 [59]" exact="Libya" post="Healthy volunteers 161 65.8 14.9 13.7 1.9 2.5 1.2"/>
  <result pre="65.8 14.9 13.7 1.9 2.5 1.2 80.1 10.6 9.3 [60]" exact="Libya" post="Patients taking maintenance VKA 231 60.6 22.5 10.0 2.2"/>
  <result pre="60.6 22.5 10.0 2.2 3.9 0.9 76.8 15.4 7.8 [61]" exact="Morocco" post="Low-dose acenocoumarol 20 55.0 25.0 5.0 10.0 0 5.0"/>
  <result pre="73.6 11.3 8.5 NA 2.4 0.9 84.2 6.8 6.4 [63]" exact="Oman" post="Patients taking maintenance warfarin 189 80.4 12.7 5.8 1.1"/>
  <result pre="80.4 12.7 5.8 1.1 0 0 89.6 7.5 2.9 [64]" exact="Saudi Arabia" post="Healthy volunteers 131 68.7 26.7 4.6 0 0 0"/>
  <result pre="68.7 26.7 4.6 0 0 0 84.3 13.4 2.3 [65]" exact="Saudi Arabia" post="Healthy volunteers 192 64.1 17.2 13.0 2.1 2.1 1.6"/>
  <result pre="61.6 19.4 13.2 2.7 3.1 0 77.9 14.0 8.1 [43]" exact="Turkey" post="Healthy volunteers 96 66.7 13.5 15.6 3.1 0 1.0"/>
  <result pre="66.7 13.5 15.6 3.1 0 1.0 81.2 9.9 8.9 [68]" exact="Turkey" post="Healthy volunteers 64 64.0 14.1 15.6 3.1 0 3.1"/>
  <result pre="64.0 14.1 15.6 3.1 0 3.1 78.9 10.2 10.9 [69]" exact="Turkey" post="Healthy volunteers 85 68.2 11.8 14.1 3.5 1.2 1.2"/>
  <result pre="68.2 11.8 14.1 3.5 1.2 1.2 81.2 10.0 8.8 [42]" exact="Turkey" post="Healthy volunteers (n = 218), outpatients with variable diagnoses"/>
  <result pre="61.7 18.0 17.2 1.0 1.1 0.8 79.4 10.6 10.0 [44]" exact="Turkey" post="Outpatients of epilepsy clinic 102 78.4 14.7 6.9 0"/>
  <result pre="60.0 18.0 13.7 1.5 3.9 1.0 76.8 12.7 9.8 [71]" exact="Turkey" post="Patients taking maintenance warfarin 100 50.0 21.0 24.0 0"/>
  <result pre="50.0 21.0 24.0 0 5.0 0 72.5 13.0 14.5 [72]" exact="Turkey" post="Patients taking maintenance anticoagulant 292 56.5 23.0 8.6 3.0"/>
  <result pre="33.3 33.3 NA 8.0 NA NA 53.3 26.0 NA [47]" exact="Egypt" post="Healthy volunteers 247 78.5 20.2 0.4 0.8 0 0"/>
  <result pre="78.5 20.2 0.4 0.8 0 0 88.9 10.9 0.2 [73]" exact="Egypt" post="Male agricultural workers 120 93.3 5.8 NA 0.8 NA"/>
  <result pre="92.0 8.0 NA 0 NA NA 96.0 4.0 NA [80]" exact="Israel" post="Healthy volunteers 140 70.7 25.0 1.4 2.9 0 0"/>
  <result pre="70.7 25.0 1.4 2.9 0 0 83.9 15.4 0.7 [81]" exact="Israel" post="Volunteers of Yemenite descent 36 77.8 19.4 0 2.8"/>
  <result pre="76.0 20.0 2.0 2.0 0 0 87.0 12.0 1.0 [57]" exact="Jordan" post="Healthy volunteers 158 78.5 18.4 0 3.2 0 0"/>
  <result pre="78.5 18.4 0 3.2 0 0 87.7 12.3 0 [82]" exact="Jordan" post="Healthy male volunteers 78 74.4 19.2 0 6.4 0"/>
  <result pre="41.0 35.0 NA 3.0 NA NA 61.5 22.0 NA [83]" exact="Lebanon" post="Healthy volunteers 161 75.8 20.5 0.6 3.1 0 0"/>
  <result pre="40.3 14.4 NA 0.005 NA NA 62.9 11.2 NA [85]" exact="Saudi Arabia" post="Healthy military recruits 97 NR 87.0 13.0 0 [86]"/>
  <result pre="Arabia Healthy military recruits 97 NR 87.0 13.0 0 [86]" exact="Saudi Arabia" post="Patients taking clopidogrel for ACS 90 67.0 3.0 0"/>
  <result pre="47.3 12.8 NA 0.3 NA NA 69.8 8.9 0 [43]" exact="Turkey" post="Healthy volunteers 94 78.1 16.7 NA 3.1 NA NA"/>
  <result pre="78.1 16.7 NA 3.1 NA NA 88.3 11.7 0 [87]" exact="Turkey" post="Healthy volunteers 404 76.0 22.3 0.7 1.0 0 0"/>
  <result pre="76.0 22.3 0.7 1.0 0 0 87.5 12.1 0.4 [44]" exact="Turkey" post="Outpatients of epilepsy clinic 102 55.9 17.6 10.8 5.9"/>
  <result pre="44.3 12.3 0 1.2 0 0 65.6 10.0 0 [89]" exact="Turkey" post="Patients taking clopidogrel for ICVD 51 70.6 25.5 0"/>
  <result pre="(%) Allelic frequencies (%) CC CT TT C T [46]" exact="Egypt" post="Healthy volunteers 50 24.0 48.0 28.0 48.0 52.0 Patients"/>
  <result pre="with drug-resistant epilepsy 63 55.6 38.1 6.3 74.6 25.4 [90]" exact="Egypt" post="Patients taking clopidogrel for ACS or PCI who experienced"/>
  <result pre="not experience MACE 106 37.7 44.3 17.9 59.9 40.1 [91]" exact="Egypt" post="Patients taking maintenance warfarin 84 29.8 54.8 15.4 57.1"/>
  <result pre="taking maintenance warfarin 84 29.8 54.8 15.4 57.1 42.9 [92]" exact="Egypt" post="Patients with hypercholesterolemia 50 38.0 40.0 22.0 58.0 42.0"/>
  <result pre="Patients with hypercholesterolemia 50 38.0 40.0 22.0 58.0 42.0 [93]" exact="Egypt" post="Patients taking imatinib for newly diagnosed Philadelphia chromosome-positive CML"/>
  <result pre="Philadelphia chromosome-positive CML 100 44.0 47.0 9.0 67.5 32.5 [94]" exact="Egypt" post="Healthy child volunteers 35 28.6 48.6 22.9 47.1 52.9"/>
  <result pre="with breast cancer 106 15.1 53.7 31.1 42.0 58.0 [101]" exact="Jordan" post="Healthy volunteers 100 17.0 50.0 33.0 42.0 58.0 [102]"/>
  <result pre="Jordan Healthy volunteers 100 17.0 50.0 33.0 42.0 58.0 [102]" exact="Jordan" post="Patients of ear, nose, and throat clinic 251 16.3"/>
  <result pre="and throat clinic 251 16.3 48.2 35.4 40.4 59.6 [103]" exact="Jordan" post="Patients receiving methotrexate for RA 159 37.7 45.3 17.0"/>
  <result pre="methotrexate for RA 159 37.7 45.3 17.0 60.4 39.6 [104]" exact="Jordan" post="Healthy female volunteers 150 26.7 43.3 30.0 48.3 51.7"/>
  <result pre="with breast cancer 150 45.3 41.3 13.3 66.0 34.0 [105]" exact="Lebanon" post="Children with ALL 127 27.6 44.1 28.3 49.6 50.4"/>
  <result pre="Children with ALL 127 27.6 44.1 28.3 49.6 50.4 [106]" exact="Morocco" post="Healthy volunteers 100 39.0 51.0 10.0 64.5 35.5 [107]"/>
  <result pre="Morocco Healthy volunteers 100 39.0 51.0 10.0 64.5 35.5 [107]" exact="Saudi Arabia" post="Healthy volunteers 179 35.2 45.2 19.6 57.8 42.2 [108]"/>
  <result pre="Arabia Healthy volunteers 179 35.2 45.2 19.6 57.8 42.2 [108]" exact="Saudi Arabia" post="Healthy female volunteers 100 93.0 5.0 2.0 95.5 4.5"/>
  <result pre="with breast cancer 100 73.0 11.0 16.0 78.5 21.5 [45]" exact="Saudi Arabia" post="Patients with PHT-responsive epilepsy 25 80.0 20.0 88.0 12.0"/>
  <result pre="Patients with PHT-resistant epilepsy 25 52.0 48.0 70.0 30.0 [43]" exact="Turkey" post="Healthy volunteers 96 29.2 46.9 24.0 52.6 47.4 [109]"/>
  <result pre="Turkey Healthy volunteers 96 29.2 46.9 24.0 52.6 47.4 [109]" exact="Turkey" post="Healthy volunteers 107 27.1 41.1 31.8 47.7 52.3 [110]"/>
  <result pre="Turkey Healthy volunteers 107 27.1 41.1 31.8 47.7 52.3 [110]" exact="Turkey" post="Healthy volunteers 174 28.2 46.0 25.9 51.1 48.9 Patients"/>
  <result pre="with CBZ-resistant epilepsy 44 29.5 59.1 11.4 59.1 40.9 [29]" exact="Turkey" post="Children with drug-responsive epilepsy 83 26.5 45.8 27.7 49.4"/>
  <result pre="with drug-resistant epilepsy 69 24.6 43.5 31.9 46.4 53.6 [111]" exact="Turkey" post="Patients receiving fentanyl for spinal anesthesia 83 28.9 54.2"/>
  <result pre="for spinal anesthesia 83 28.9 54.2 16.9 56.0 44.0 [112]" exact="Turkey" post="Patients with normal CAG 85 27.1 41.2 31.8 47.6"/>
  <result pre="found on CAG 113 27.4 48.7 23.9 51.8 48.2 [113]" exact="Turkey" post="Healthy male volunteers 102 26.5 49.0 24.5 51.0 49.0"/>
  <result pre="with primary infertility 192 27.6 57.3 15.1 56.3 43.7 [114]" exact="Turkey" post="Healthy volunteers 130 25.4 44.6 30.0 47.7 52.3 Patients"/>
  <result pre="familial Mediterranean fever 142 16.9 59.9 23.2 46.8 53.2 [115]" exact="Turkey" post="Healthy volunteers 250 27.2 42.4 30.4 48.4 51.6 Patients"/>
  <result pre="familial Mediterranean fever 309 20.4 55.3 24.3 48.1 51.9 [116]" exact="Turkey" post="Patients with familial Mediterranean fever 41 3.7 54.2 43.4"/>
  <result pre="familial Mediterranean fever 41 3.7 54.2 43.4 29.2 70.8 [117]" exact="Turkey" post="Renal transplant recipients taking tacrolimus 92 30.4 47.8 21.7"/>
  <result pre="recipients taking tacrolimus 92 30.4 47.8 21.7 54.3 45.7 [118]" exact="Turkey" post="Renal transplant recipients taking cyclosporine who did not develop"/>
  <result pre="developed gingival hyperplasia 40 32.5 37.5 30.0 51.3 48.7 [119]" exact="Turkey" post="Patients taking clozapine who did not develop agranulocytosis 91"/>
  <result pre="who developed agranulocytosis 10 20.0 60.0 20.0 50.0 50.0 [120]" exact="Turkey" post="Patients with non-small-cell lung cancer 79 24.1 62.0 13.9"/>
  <result pre="non-small-cell lung cancer 79 24.1 62.0 13.9 55.1 44.9 [121]" exact="Turkey" post="Healthy volunteers 150 NR 52.3 47.7 Patients with colorectal"/>
  <result pre="of 10–20 mg/L [24]. A study of patients originating from" exact="India" post="indicated that those with the CYP2C9*1/*3 genotype were more"/>
 </snippets>
</snippetsTree>
